Find Your Daily Voice
Kingston
Hurley
Port Ewen
Esopus
Your Local News for Kingston, Hurley, Port Ewen and Esopus, New York
Wednesday, nov 6
66°
Follow
News
Schools
Business
Obituaries
Police & Fire
Weather
Lifestyle
Politics
Sports
Traffic
Real Estate
Tags
Jobs
Shop
Support Us
Kingston
Hurley
Port Ewen
Esopus
Follow
Find Your Daily Voice
News
Schools
Business
Obituaries
Police & Fire
Weather
Lifestyle
Politics
Sports
Traffic
Real Estate
Tags
Jobs
Shop
Support Us
Home
About us
All sites
Advertise with us
Contact us
Terms of use
Privacy policy
Code of ethics
Site Map
© 2024 Cantata Media
66°
Wednesday, nov 6
Tag:
Clinical Trials
News
Covid-
19: Pfizer Asks FDA For Emergency Use Authorization Of Vaccine For Children Under 5
New York-based Pfizer and its European partner BioNTech has requested that the Food and Drug Administration (FDA) expand the use of its COVID-19 vaccine to include children between the ages of 6 months and 5 years old, officials announced. On Tuesday, Feb. 1, citing a host of clinical trials, the pharmaceutical company announced it is seeking emergency use authorization (EUA) to admit the vaccine to a wider range of children. Currently, the vaccine is only approved for children 5 years old and older. Pfizer said that it plans to complete its EUA submission “in the coming days,” and has alre…
News
Covid-
19: Booster Shot Significantly Raises Antibody Levels Against Omicron, Moderna Says
A Moderna COVID-19 vaccine booster shot significantly raises the level of antibodies against the new Omicron variant, the company announced on Monday morning, Dec. 20. The currently authorized 50-microgram booster neutralized antibody levels against Omicron approximately 37-fold compared to pre-boost levels and a 100-micrograms dose increased neutralizing antibody levels approximately 83-fold compared to pre-boost levels, the Cambridge, Massachusetts-based company said in a statement. The results are based on laboratory testing. “The dramatic increase in COVID-19 cases from the O…
News
Covid-
19: Drugmaker To Seek Emergency Approval For Pill To Treat Virus
A new pharmaceutical company is throwing its hat in the ring as the country continues its fight against COVID-19. Merck and Ridgeback Biotherapeutics announced on Friday, Oct. 1 that it is planning to apply for federal emergency approval of a pill that can reportedly help prevent hospitalizations and deaths in COVID-19 patients. According to the company, trials have found that the pill - dubbed molnupiravir - could potentially reduce the risk of hospitalization or death in patients with mild to moderate COVID-19 by approximately 50 percent. The results of the late-stage trial have bee…
News
Covid-
19: CDC Advisory Panel Endorses Use Of Pfizer Vaccine In Children 12 And Up
A panel of experts advising the Centers for Disease Control and Prevention (CDC) voted to move forward with the approval process for the use of the Pfizer COVID-19 vaccine among children between the ages of 12 and 15. By a 14-0 vote on Wednesday afternoon, May 12, the CDC panel recommended the use of the Pfizer vaccine in children 12 and up, with the decision now moving forward to CDC Director Dr. Rochelle Walensky for final approval. Once approved by Walensky, which is expected to happen quickly, it will be at states’ discretion about whether or not to move forward vaccinating children. …
News
Covid-
19: NY Woman Tests Positive One Month After Getting Second Vaccine Dose
A New York woman who was fully vaccinated for COVID-19 tested positive a month after receiving her second dose. Melanie Rosen, who lives in Valley Stream on Long Island, received her second dose of the Moderna COVID-19 vaccine in Queens on Saturday, Feb. 20, but it wasn’t enough to keep her from contracting the virus for a second time last month. According to multiple reports, including PIX 11, Rosen was so confident in the vaccine that she willingly went to visit with a group of friends without wearing a mask, although they were not vaccinated. While it hasn’t been confirmed that she cau…
Lifestyle
Covid-
19: Little Brown Pill Could Be Difference Maker In Fight Against Virus
Scientists may have cracked the code to help in the fight against COVID-19 and potential future pandemics. Though still in clinical trials, the “little brown pill” molnupiravir may give doctors and researchers a new tool and treatment as the country continues combating the latest wave of COVID-19 cases. Merck (also known as MSD), and Ridgeback Biotherapeutics, LP announced earlier this month that they ran a randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability, and efficacy of the pill to eliminate the strain that causes COVID-19. According to the prelimin…
News
Covid-
19: Johns Hopkins Seeks Local Volunteers For Treatment Of Virus
Johns Hopkins University is looking for volunteers who are currently infected with COVID-19 to help test a new treatment that uses antibodies individuals who have already recovered from the illness. Participants will be compensated, according to the University, and trials will be conducted at Vassar Brothers Medical Center in Poughkeepsie. Eligible candidates for the study include those who tested positive for the virus no more than five days ago or those who have no symptoms despite coming into contact with someone who tested positive within three days. Researchers hope to det…
News
Covid-
19: Scientists Have High Hopes For Potential Breakthrough Virus Blocker
A team of scientists has high hopes for a potential breakthrough blocker for the novel strain of coronavirus (COVID-19). It has discovered that strains of medical cannabis may help prevent contracting COVID infections. At least a dozen cannabis plants of the hundreds tested were high in CBD that appeared to affect the ACE2 pathways that the virus uses to access the body, the researchers from the University of Lethbridge in Alberta, Canada discovered. The findings won't lead to a vaccine, but rather other delivery methods that could make people more resistant to COVID-19, says the…
66°
